| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
62,187 | 64,232 | 65,353 | 59,333 | 49,698 | 42,062 | 0 | 0 | 0 |
General and administrative | ||||||||
22,912 | 22,428 | 23,141 | 24,355 | 21,384 | 18,621 | 0 | 0 | 0 |
Total operating expenses | ||||||||
85,099 | 86,660 | 88,494 | 83,688 | 71,082 | 60,683 | 0 | 0 | 0 |
Loss from operations | ||||||||
-85,099 | -86,660 | -88,494 | -83,688 | -71,082 | -60,683 | 0 | 0 | 0 |
Other (expense) income: | ||||||||
Interest income | ||||||||
1,479 | 1,693 | 1,822 | 1,768 | 1,455 | 1,118 | 0 | 0 | 0 |
Interest expense | ||||||||
1,407 | 977 | 1,036 | 1,021 | 1,014 | 1,005 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||
- | -252 | 261 | 317 | 316 | 918 | 0 | 0 | 0 |
Other expense | ||||||||
56 | 59 | 80 | 236 | 246 | 256 | 0 | 0 | 0 |
Total other (expense) income, net | ||||||||
-564 | 329 | 445 | 194 | -121 | -1,061 | 0 | 0 | 0 |
Net loss | ||||||||
-85,632 | -86,300 | -88,005 | -83,450 | -71,159 | -61,700 | 0 | 0 | 0 |
Net loss per share —basic and diluted | ||||||||
-0.64 | -0.23 | -0.74 | -0.83 | -1.56 | -3.87 | -3.38 | -2.57 | -2.27 |
Weighted-average common shares outstanding —basic and diluted | ||||||||
30,333 | 30,325 | 29,856 | 29,667 | 12,963 | 5,730 | 5,146 | 4,811 | 4,743 |